P&G Reflection

We here at P&G were presented with some very interesting and intriguing options for reducing time in data collection during our clinical trials. The options that we were presented were to increase our human capital, digital imaging with faxing, or use Web-Enabled EDC system.  Going into the presentation I had conflicting ideas of how we should move forward, but after the presentation I am sure that I have come to my decision.

One of the most important questions that I needed answered going into the presentation was if a reduced time a drug spent in clinical trial really resulted in increased sales. There were many pros and cons to the different options we were presented, but we were able to see that a drug that spends less time in clinical trial using the Web-Enabled EDC. Using Web-Enabled EDC we can see that a drug does not have a long “data-lock” time, meaning the work that goes into filing the trial is reduced. With the reduced time we are able to capture the full value of the drug. We can also see other expenses being cut with reduced paper and staffing level.

Going into the presentation I felt an investment in human capital would be a logical recommendation as the staff that we currently have is familiar with the program. In trials they were used to the paper format and were comfortable with it. Why fix something that was not broken? I was not thinking of the potential future costs of what we at P&G could be receiving. Looking into the future it is necessary to be innovative and this Web-Enabled EDC system will do just that. It will provide us a good opportunity to increase our fast growing pharmaceutical business while also helping to keep future costs down. In my opinion, the Web-enabled EDC is the best solution for P&G.